Attenuated Peptide YY Release in Obese Subjects Is Associated with Reduced Satiety
Carel W. le Roux(University College Dublin), S.R. Bloom(Hammersmith Hospital), Michael Patterson(Hammersmith Hospital), Simon Aylwin(King's College Hospital NHS Foundation Trust), James Gardiner(Hammersmith Hospital), Katie Wynne(Hunter Medical Research Institute), Cynthia-Michelle Borg, Rachel L. Batterham(University College Hospital), Mohammad A. Ghatei(Hammersmith Hospital), A.S.H. Kent(Hammersmith Hospital), Royce P Vincent(Hammersmith Hospital)
Cited by 544
Related Papers
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k
Inhibition of Food Intake in Obese Subjects by Peptide YY<sub>3–36</sub>
|New England Journal of Medicine|2003|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k
Morbidity and mortality associated with obesity
|Annals of Translational Medicine|2017|1k